Source: International Congress 2017 – CC7 Pneumonia, pneumonitis, or progressive disease during immunotherapy in lung cancer?



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bostantzoglou (Athens, Greece). Case 3: It is …. International Congress 2017 – CC7 Pneumonia, pneumonitis, or progressive disease during immunotherapy in lung cancer?

Member's Comments

No comment yet.

Related content which might interest you: Case 3 Source: Eur Respir Monogr 2018; 80: 291-293 Year: 2018 Case 3 Source: Eur Respir Monogr 2018; 81: 396-398 Year: 2018 Case 3 Source: Eur Respir Monogr 2021; 93: 338-341 Year: 2021 Case 3 Source: Eur Respir Monogr 2020; 88: 314-317 Year: 2020 Case 3 Source: Eur Respir Monogr 2019; 85: 187-191 Year: 2019 Case 4 Source: Eur Respir Monogr 2018; 81: 399-402 Year: 2018 Mechanisms underlying fixed airflow obstruction and exacerbations Source: Eur Respir Monogr 2019; 84: 345-347 Year: 2019 Case 4 Source: Eur Respir Monogr 2021; 93: 342-345 Year: 2021 a1-Antitrypsin Deficiency Source: Eur Respir Monogr 2019; 85: 192-195 Year: 2019 Case 4 Source: Eur Respir Monogr 2019; 85: 192-195 Year: 2019 Case 2 Source: Eur Respir Monogr 2018; 80: 287-290 Year: 2018 Case 2 Source: Eur Respir Monogr 2020; 88: 305-313 Year: 2020 Case 2 Source: Eur Respir Monogr 2019; 85: 184-186 Year: 2019 Case 2 Source: Eur Respir Monogr 2021; 93: 332-337 Year: 2021 Case 2 Source: International Congress 2017 – CC4 Severe asthma  Year: 2017 Case 2 Source: Eur Respir Monogr 2018; 81: 391-395 Year: 2018 Case 2 Source: International Congress 2018 – CC7 Severe asthma Year: 2018 Case 1 Source: Eur Respir Monogr 2021; 93: 326-331 Year: 2021 Case 1 Source: International Congress 2018 – CC7 Severe asthma Year: 2018 Case 1 Source: Eur Respir Monogr 2020; 88: 300-304 Year: 2020